These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2871517)

  • 1. Possible role of neuropeptide degrading enzymes on thyroliberin secretion in fetal hypothalamic cultures grown in serum free medium.
    Faivre-Bauman A; Loudes C; Barret A; Tixier-Vidal A; Bauer K
    Neuropeptides; 1986; 7(2):125-38. PubMed ID: 2871517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the role of a pyroglutamyl peptidase, a post-proline cleaving enzyme and a post-proline dipeptidyl amino peptidase, each purified from the soluble fraction of guinea-pig brain, in the degradation of thyroliberin in vitro.
    Browne P; O'Cuinn G
    Eur J Biochem; 1983 Dec; 137(1-2):75-87. PubMed ID: 6140164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibitors of pyroglutamyl peptidase I and prolyl endopeptidase do not change the in vitro release of TRH or its content in rodent brain.
    Charli JL; Mendez M; Joseph-Bravo P; Wilk S
    Neuropeptides; 1987; 9(4):373-8. PubMed ID: 2886950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogenesis of neuropeptide degrading enzymes in the mouse brain.
    Faivre-Bauman A; Knisatschek H; Tixier-Vidal A; Bauer K
    J Neurosci Res; 1981; 6(1):63-74. PubMed ID: 6111613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for pyroglutamyl peptidase I and prolyl endopeptidase activities in the rat insulinoma cell line RINm 5F: lack of relationship with TRH metabolism.
    Salers P; Ouafik LH; Giraud P; Dutour A; Maltese JY; Oliver C
    Mol Cell Biochem; 1991 Jul; 106(1):15-24. PubMed ID: 1681421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of TRH-degrading enzymes.
    Wilk S
    Ann N Y Acad Sci; 1989; 553():252-64. PubMed ID: 2566296
    [No Abstract]   [Full Text] [Related]  

  • 7. Delineation of a particulate thyrotropin-releasing hormone-degrading enzyme in rat brain by the use of specific inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase.
    Friedman TC; Wilk S
    J Neurochem; 1986 Apr; 46(4):1231-9. PubMed ID: 2869108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the role of prolyl endopeptidase and pyroglutamyl peptidase I in the metabolism of LHRH and TRH in brain.
    Mendez M; Cruz C; Joseph-Bravo P; Wilk S; Charli JL
    Neuropeptides; 1990 Oct; 17(2):55-62. PubMed ID: 1980725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of substrate requirements, kinetic properties, and competive inhibitors of the enzymes catabolizing TRH in rat brain.
    Busby WH; Youngblood WW; Kizer JS
    Brain Res; 1982 Jun; 242(2):261-70. PubMed ID: 6126250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase on TRH degradation in rat serum.
    Friedman TC; Wilk S
    Biochem Biophys Res Commun; 1985 Oct; 132(2):787-94. PubMed ID: 2865955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of immunoreactive TRH in serum-free cultures of mouse hypothalamic cells.
    Loudes C; Faivre-Bauman A; Barret A; Grouselle D; Puymirat J; Tixier-Vidal A
    Brain Res; 1983 Aug; 285(2):231-4. PubMed ID: 6412967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyroglutamyl peptidase II inhibition specifically increases recovery of TRH released from rat brain slices.
    Charli JL; Mendez M; Vargas MA; Cisneros M; Assai M; Joseph-Bravo P; Wilk S
    Neuropeptides; 1989 Oct; 14(3):191-6. PubMed ID: 2575716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid status regulates particulate but not soluble TRH-degrading pyroglutamate aminopeptidase activity in the rat liver.
    Scharfmann R; Ebiou JC; Morgat JL; Aratan-Spire S
    Acta Endocrinol (Copenh); 1990 Jul; 123(1):84-9. PubMed ID: 1975148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of a particulate thyrotropin-releasing hormone-degrading pyroglutamate aminopeptidase activity in rat liver.
    Scharfmann R; Morgat JL; Aratan-Spire S
    Neuroendocrinology; 1989 Apr; 49(4):442-8. PubMed ID: 2566131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of two topologically distinct TRH-degrading pyroglutamate aminopeptidase activities in the rat liver.
    Scharfmann R; Aratan-Spire S
    Regul Pept; 1991 Feb; 32(2):75-83. PubMed ID: 1674616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catabolism of thyroliberin by rat adenohypophyseal tissue extract.
    Bauer K; Kleinkauf H
    Eur J Biochem; 1980 May; 106(1):107-17. PubMed ID: 6122566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyroglutamyl peptidase: an overview of the three known enzymatic forms.
    Cummins PM; O'Connor B
    Biochim Biophys Acta; 1998 Dec; 1429(1):1-17. PubMed ID: 9920379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Demonstration of neuronal activities in primary cultures from fetal mouse hypothalamus maintained in a serum-free medium].
    Faivre-Bauman A; Rosenbaum E; Puymirat J; Tixier-Vidal A
    C R Seances Acad Sci D; 1980 Mar; 290(13):885-7. PubMed ID: 6104544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some events of thyrotropin-releasing hormone metabolism are regulated in lactating and cycling rats.
    Uribe RM; Joseph-Bravo P; Pasten J; Ponce G; Méndez M; Covarrubias L; Charli JL
    Neuroendocrinology; 1991 Nov; 54(5):493-8. PubMed ID: 1684228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of a thyrotropin-releasing hormone-degrading enzyme in GH3 cells: induction of pyroglutamyl peptidase I by 3,5,3'-triiodothyronine.
    Suen CS; Wilk S
    Endocrinology; 1987 Aug; 121(2):770-5. PubMed ID: 2885183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.